Global Liquid Biopsy Products Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI01244378

Publication Date:

January 4, 2024

Pages:

116

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Liquid Biopsy Products market size was valued at US$ 1676.7 million in 2023. With growing demand in downstream market, the Liquid Biopsy Products is forecast to a readjusted size of US$ 8668.9 million by 2030 with a CAGR of 26.5% during review period.
The research report highlights the growth potential of the global Liquid Biopsy Products market. Liquid Biopsy Products are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Liquid Biopsy Products. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Liquid Biopsy Products market.
Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.

This report mainly covers the Liquid Biopsy Products product type by technology (circulating Tumor Cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (or exosomes)), by sample type (blood, urine and other bio fluids (Tissue fluids and Saliva based)), while we can also offer any product survey report related to the liquid biopsy products industry chain.
The major players in global Liquid Biopsy Products market include RainDanceTechnologies, Biocartis, Qiagen, etc. The top 3 players occupy about 15% shares of the global market. North America is the main market. CTCs is the main type, with a share about 65%. Blood Sample is the main application, which holds a share about 90%.
Key Features:
The report on Liquid Biopsy Products market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Liquid Biopsy Products market. It may include historical data, market segmentation by Type (e.g., CTCs, ctDNA), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Liquid Biopsy Products market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Liquid Biopsy Products market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Liquid Biopsy Products industry. This include advancements in Liquid Biopsy Products technology, Liquid Biopsy Products new entrants, Liquid Biopsy Products new investment, and other innovations that are shaping the future of Liquid Biopsy Products.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Liquid Biopsy Products market. It includes factors influencing customer ' purchasing decisions, preferences for Liquid Biopsy Products product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Liquid Biopsy Products market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Liquid Biopsy Products market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Liquid Biopsy Products market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Liquid Biopsy Products industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Liquid Biopsy Products market.
Market Segmentation:
Liquid Biopsy Products market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
CTCs
ctDNA
Exosomes
Segmentation by application
Blood Sample
Urine Sample
Other Bio Fluids
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
RainDanceTechnologies
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Cynvenio
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Liquid Biopsy Products Market Size 2019-2030
2.1.2 Liquid Biopsy Products Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Liquid Biopsy Products Segment by Type
2.2.1 CTCs
2.2.2 ctDNA
2.2.3 Exosomes
2.3 Liquid Biopsy Products Market Size by Type
2.3.1 Liquid Biopsy Products Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Liquid Biopsy Products Market Size Market Share by Type (2019-2024)
2.4 Liquid Biopsy Products Segment by Application
2.4.1 Blood Sample
2.4.2 Urine Sample
2.4.3 Other Bio Fluids
2.5 Liquid Biopsy Products Market Size by Application
2.5.1 Liquid Biopsy Products Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Liquid Biopsy Products Market Size Market Share by Application (2019-2024)
3 Liquid Biopsy Products Market Size by Player
3.1 Liquid Biopsy Products Market Size Market Share by Players
3.1.1 Global Liquid Biopsy Products Revenue by Players (2019-2024)
3.1.2 Global Liquid Biopsy Products Revenue Market Share by Players (2019-2024)
3.2 Global Liquid Biopsy Products Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Liquid Biopsy Products by Regions
4.1 Liquid Biopsy Products Market Size by Regions (2019-2024)
4.2 Americas Liquid Biopsy Products Market Size Growth (2019-2024)
4.3 APAC Liquid Biopsy Products Market Size Growth (2019-2024)
4.4 Europe Liquid Biopsy Products Market Size Growth (2019-2024)
4.5 Middle East & Africa Liquid Biopsy Products Market Size Growth (2019-2024)
5 Americas
5.1 Americas Liquid Biopsy Products Market Size by Country (2019-2024)
5.2 Americas Liquid Biopsy Products Market Size by Type (2019-2024)
5.3 Americas Liquid Biopsy Products Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Liquid Biopsy Products Market Size by Region (2019-2024)
6.2 APAC Liquid Biopsy Products Market Size by Type (2019-2024)
6.3 APAC Liquid Biopsy Products Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Liquid Biopsy Products by Country (2019-2024)
7.2 Europe Liquid Biopsy Products Market Size by Type (2019-2024)
7.3 Europe Liquid Biopsy Products Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Liquid Biopsy Products by Region (2019-2024)
8.2 Middle East & Africa Liquid Biopsy Products Market Size by Type (2019-2024)
8.3 Middle East & Africa Liquid Biopsy Products Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Liquid Biopsy Products Market Forecast
10.1 Global Liquid Biopsy Products Forecast by Regions (2025-2030)
10.1.1 Global Liquid Biopsy Products Forecast by Regions (2025-2030)
10.1.2 Americas Liquid Biopsy Products Forecast
10.1.3 APAC Liquid Biopsy Products Forecast
10.1.4 Europe Liquid Biopsy Products Forecast
10.1.5 Middle East & Africa Liquid Biopsy Products Forecast
10.2 Americas Liquid Biopsy Products Forecast by Country (2025-2030)
10.2.1 United States Liquid Biopsy Products Market Forecast
10.2.2 Canada Liquid Biopsy Products Market Forecast
10.2.3 Mexico Liquid Biopsy Products Market Forecast
10.2.4 Brazil Liquid Biopsy Products Market Forecast
10.3 APAC Liquid Biopsy Products Forecast by Region (2025-2030)
10.3.1 China Liquid Biopsy Products Market Forecast
10.3.2 Japan Liquid Biopsy Products Market Forecast
10.3.3 Korea Liquid Biopsy Products Market Forecast
10.3.4 Southeast Asia Liquid Biopsy Products Market Forecast
10.3.5 India Liquid Biopsy Products Market Forecast
10.3.6 Australia Liquid Biopsy Products Market Forecast
10.4 Europe Liquid Biopsy Products Forecast by Country (2025-2030)
10.4.1 Germany Liquid Biopsy Products Market Forecast
10.4.2 France Liquid Biopsy Products Market Forecast
10.4.3 UK Liquid Biopsy Products Market Forecast
10.4.4 Italy Liquid Biopsy Products Market Forecast
10.4.5 Russia Liquid Biopsy Products Market Forecast
10.5 Middle East & Africa Liquid Biopsy Products Forecast by Region (2025-2030)
10.5.1 Egypt Liquid Biopsy Products Market Forecast
10.5.2 South Africa Liquid Biopsy Products Market Forecast
10.5.3 Israel Liquid Biopsy Products Market Forecast
10.5.4 Turkey Liquid Biopsy Products Market Forecast
10.5.5 GCC Countries Liquid Biopsy Products Market Forecast
10.6 Global Liquid Biopsy Products Forecast by Type (2025-2030)
10.7 Global Liquid Biopsy Products Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 RainDanceTechnologies
11.1.1 RainDanceTechnologies Company Information
11.1.2 RainDanceTechnologies Liquid Biopsy Products Product Offered
11.1.3 RainDanceTechnologies Liquid Biopsy Products Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 RainDanceTechnologies Main Business Overview
11.1.5 RainDanceTechnologies Latest Developments
11.2 Biocartis
11.2.1 Biocartis Company Information
11.2.2 Biocartis Liquid Biopsy Products Product Offered
11.2.3 Biocartis Liquid Biopsy Products Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Biocartis Main Business Overview
11.2.5 Biocartis Latest Developments
11.3 Qiagen
11.3.1 Qiagen Company Information
11.3.2 Qiagen Liquid Biopsy Products Product Offered
11.3.3 Qiagen Liquid Biopsy Products Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Qiagen Main Business Overview
11.3.5 Qiagen Latest Developments
11.4 Guardant Health
11.4.1 Guardant Health Company Information
11.4.2 Guardant Health Liquid Biopsy Products Product Offered
11.4.3 Guardant Health Liquid Biopsy Products Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Guardant Health Main Business Overview
11.4.5 Guardant Health Latest Developments
11.5 MDxHealth
11.5.1 MDxHealth Company Information
11.5.2 MDxHealth Liquid Biopsy Products Product Offered
11.5.3 MDxHealth Liquid Biopsy Products Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 MDxHealth Main Business Overview
11.5.5 MDxHealth Latest Developments
11.6 Pathway Genomics
11.6.1 Pathway Genomics Company Information
11.6.2 Pathway Genomics Liquid Biopsy Products Product Offered
11.6.3 Pathway Genomics Liquid Biopsy Products Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Pathway Genomics Main Business Overview
11.6.5 Pathway Genomics Latest Developments
11.7 NeoGenomics Laboraories
11.7.1 NeoGenomics Laboraories Company Information
11.7.2 NeoGenomics Laboraories Liquid Biopsy Products Product Offered
11.7.3 NeoGenomics Laboraories Liquid Biopsy Products Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 NeoGenomics Laboraories Main Business Overview
11.7.5 NeoGenomics Laboraories Latest Developments
11.8 Sysmex Inostics
11.8.1 Sysmex Inostics Company Information
11.8.2 Sysmex Inostics Liquid Biopsy Products Product Offered
11.8.3 Sysmex Inostics Liquid Biopsy Products Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Sysmex Inostics Main Business Overview
11.8.5 Sysmex Inostics Latest Developments
11.9 Cynvenio
11.9.1 Cynvenio Company Information
11.9.2 Cynvenio Liquid Biopsy Products Product Offered
11.9.3 Cynvenio Liquid Biopsy Products Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Cynvenio Main Business Overview
11.9.5 Cynvenio Latest Developments
11.10 Menarini Silicon Biosystems
11.10.1 Menarini Silicon Biosystems Company Information
11.10.2 Menarini Silicon Biosystems Liquid Biopsy Products Product Offered
11.10.3 Menarini Silicon Biosystems Liquid Biopsy Products Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Menarini Silicon Biosystems Main Business Overview
11.10.5 Menarini Silicon Biosystems Latest Developments
11.11 Adaptive Biotechnologies
11.11.1 Adaptive Biotechnologies Company Information
11.11.2 Adaptive Biotechnologies Liquid Biopsy Products Product Offered
11.11.3 Adaptive Biotechnologies Liquid Biopsy Products Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Adaptive Biotechnologies Main Business Overview
11.11.5 Adaptive Biotechnologies Latest Developments
11.12 Biocept
11.12.1 Biocept Company Information
11.12.2 Biocept Liquid Biopsy Products Product Offered
11.12.3 Biocept Liquid Biopsy Products Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Biocept Main Business Overview
11.12.5 Biocept Latest Developments
11.13 Angle plc
11.13.1 Angle plc Company Information
11.13.2 Angle plc Liquid Biopsy Products Product Offered
11.13.3 Angle plc Liquid Biopsy Products Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Angle plc Main Business Overview
11.13.5 Angle plc Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂